Abstract
La reacción adversa a medicamentos es un problema importante para la salud de pacientes en manejo hospitalario, encontrado de manera regular durante la práctica médica y cuya asociación no identificamos de forma oportuna, pero que aumentan la morbimortalidad y la estancia hospitalaria; en este artículo presentamos el caso clínico de un paciente con encefalopatía severa asociada al uso de cefepima, el deterioro clínico evidenciado durante su proceso de hospitalización y el razonamiento a través del cual se identificó una reacción adversa tipo A como causa de encefalopatía.
Highlights
The adverse reaction to medications represents a major problem for the health of patients in hospital management, which we encounter on a regular basis during medical practice and whose association we do not identify in a timely manner, but increase morbidity and mortality and hospital stay; In this article we present the clinical case of a patient with severe encephalopathy associated with the use of cefepima, the clinical deterioration evidenced during the hospitalization process and the reasoning through which an adverse type A reaction was identified as a cause of encephalopathy
Existen factores de riesgo asociados que pueden facilitar el delirium; edad y el género (frecuente en hombres (70%), edad media de 68,9 años) son los principales factores descritos, sin embargo, existen otros como: niveles séricos de creatinina, bun, albumina, sodio; historia previa de delirium, isquemia cerebral, hipertensión, ventilación mecánica, infección y uso de medicamentos antipsicóticos [18], que a su vez se asocia a un mayor riesgo de complicaciones durante la hospitalización [16]
Risk of stroke in long-term dialysis patients compared with the general population, Am. J
Summary
The adverse reaction to medications represents a major problem for the health of patients in hospital management, which we encounter on a regular basis during medical practice and whose association we do not identify in a timely manner, but increase morbidity and mortality and hospital stay; In this article we present the clinical case of a patient with severe encephalopathy associated with the use of cefepima, the clinical deterioration evidenced during the hospitalization process and the reasoning through which an adverse type A reaction was identified as a cause of encephalopathy.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Revista Colombiana de Ciencias Químico-Farmacéuticas
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
